Quarterly ResultJul 28, 2026, 05:01 PM
Acadia Healthcare Q2 Revenue Flat; Net Income Down 64% to $10.9M
AI Summary
Acadia Healthcare reported second-quarter 2026 financial results, with revenue remaining approximately flat at $865.8 million. Net income attributable to Acadia significantly decreased by 64% to $10.9 million, and Adjusted EBITDA fell by 26% to $149.2 million, primarily due to a $28.6 million adjustment to professional and general liability reserves. The company expanded its operations by adding 240 licensed beds and two new Comprehensive Treatment Center locations, and updated its full-year 2026 financial guidance, including a slight increase in the lower end of its revenue and Adjusted EBITDA ranges.
Key Highlights
- Q2 2026 Revenue totaled $865.8 million, approximately flat YoY.
- Q2 2026 Net income attributable to Acadia was $10.9 million, down 64% YoY.
- Q2 2026 Adjusted net income was $35.1 million, or $0.38 per diluted share, down 54% YoY.
- Q2 2026 Adjusted EBITDA was $149.2 million, down 26% YoY.
- Q2 2026 Operating cash flows increased to $162.1 million from $133.5 million YoY.
- Added 240 licensed beds from newly constructed facilities and opened two new CTC locations.
- Updated full-year 2026 revenue guidance to $3.40 to $3.45 billion.
- Updated full-year 2026 Adjusted EPS guidance to $1.45 to $1.60.
Price Impact
More from ACHC